Interleukin-13 responsiveness and interleukin-13 receptor expression in non-Hodgkin's lymphoma and reactive lymph node B cells. Modulation by CD40 activation

European Cytokine Network

Volumn 8, Issue 1, 1997, Pages 19-27

  Billard, Christian ^a   Caput, Daniel ^b   Vita, Natalio ^b   Ferrara, Pascual ^b   Orrico, Mireille ^a   Gaulard, Philippe ^c   Boumsell, Laurence ^a   Bensussan, Armand ^a   Farcet, Jean Pierre ^a  

^a INSERM   (France)

^b SANOFI   (France)

^c HENRI MONDOR HOSPITAL   (France)

Author keywords

CD40 activation; IL 10; IL 13; IL 13 receptors; IL 4; NHL and reactive lymph node B cells

Indexed keywords

CD40 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 13 RECEPTOR;

B LYMPHOCYTE; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOPATHOLOGY; LYMPH NODE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE; LYMPHOCYTE PROLIFERATION; NONHODGKIN LYMPHOMA; PROTEIN EXPRESSION; RADIOASSAY; REVIEW;

EID: 0030936534     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Mac Lenman I C M. 1994. Germinal centers. Ann. Rev. Immnnol. 12:117.
2. Nossal G J V. 1994. Differentiation of the secondary B-lymphocyte repertoire: the germinal center reaction. Immnnol. Rev. 137:173.
3. Foy T M, Laman J D, Ledbetter J A, Aruffo A, Claassen E, Noelle R J. 1994. gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory. J. Exp. Med. 180:157.
4. Arpin C, Dechanet J, Van Kooten C, Merville P, Grouard G, Brière F, Banchereau J, Liu Y J. 1995. Generation of B cells and plasma cells. Science 268:720.
5. Galibert L, Durand I, Banchereau J, Roussel F. 1994. CD40-activated surface IgD-positive lymphocytes constitute the long term IL-4-dependent proliferating B cell pool. J Immnnol. 152:22.
6. Rousset F, Garcia E, Defrance T, Péronne C, Vezzio N, Hsu D H, Kastelein R, Moore K W, Banchereau J. 1992. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc. Natl. Acad. Sci. USA 89:1890.
7. Zurawski G, de Vries J F. 1994. Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol. Today 15:19.
8. Minty A J. 1996. Structure, function and mechanism of action of interleukin-13. In : Aggarwal B D, Gutterman J G Eds, Human cytokines: Handbook for basic and clinical research, vol. 2. : Blackwell Science, 97.
9. McKenzie A N J, Kulpepper J A, de Waal Maleyfit R, Brière F, Punnonen J, Aversa G, Sato A, Cockx B G, Menon S, de Vries J E, Banchereau J, Zurawski G. 1993. Interleukin-13, a T-cell-derived cytokine that regulates human monocyte and B-cell function. Proc. Natl. Acad. Sci. USA 90:3735.
10. Defrance T, Carayon P, Billian G, Guillemot J C, Minty A, Caput D, Ferrara P. 1994. Interleukin 13 is a B cell stimulating factor. J. Exp. Med. 179:135.
11. Vita N, Lefort S, Laurent P, Caput D, Ferrara P. 1995. Characterization of the interleukin 13 receptor and comparison with the interleukin 4 receptor on several cell types. J. Biol. Chem. 270:3512.
12. Obiri N I, Debinski W, Leonard W J, Puri R K. 1995. Receptor for interleukin 13. Interaction with interleukin 4 by a mechanism that does not involve the common g chain shared by receptors for interleukins 2, 4, 7, 9 and 15. J. Biol. Chem. 270:8797.
13. Hilton D J, Zhang J G, Metcalf D, Alexander W S, Nicola N A, Willson T A. 1996. Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc. Natl. Acad. Sci. USA 93:497.
14. Zurawski S M, Chomarat P, Djossou O, Bidaud C, McKenzie A N J, Miossec P, Banchereau J, Zurawski G. 1995. The primary binding subunit of the human interleukin-4 receptor is also a component of the interleukine-13 receptor. J. Biol. Chem. 270: 13869.
15. Lin J X, Migone T S, Tsang M, Friedmann M, Weatherbee J A, Zhou L, Yamauchi A, Bloom E T, Mietz J, John S, Leonard W J. 1995. The role of shared receptor motif and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13 and IL-15. Immunity 2:331.
16. Harris N L, Jaffe E S, Stein H, Banks P M, Chan J K C, Cleary M L, Delsol G, De Wolf-Peeters C, Falini B, Gatter K C, Grogan T M, Isaacsson P G, Knowles D M, Mason D Y, Muller-Hermelink H K, Pileri S A, Piris M A, Ralfkiaer E R, Warnke A. 1994. A revised european-american classification of lymphoid neoplasms: a proposal from the International lymphoma study group. Blood 84:1361.
17. Billard C, Ferbus D, Diez R, Kolb J P, Mathiot C, Belanger C, Auzanneau G, Varet B, Falcoff E, Dumont J. 1991. Correlation between the biological and therapeutic effects of interferon-alpha in low-grade nodular lymphoma: lack of in vivo down-regulation and reduced affinity of IFN-α receptors in unresponsive patients. Leuk. Res. 15:121.
18. Minty A, Chalon P, Derocq J M, Dumont X, Guillemot J. C., Kaghad M, Labit C, Leplatois P, Liauzun P, Miloux B, Minty A, Casellas P, Loison G Lupker J, Shire D, Ferrara P, Caput D. 1994. Interleukin-13 is a new lymphokine regulating inflammatory and immune responses. Nature 362:248.
19. Clark E A, Ledbetter J A. 1996. Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp 35 and Bp 50. Proc. Natl. Acad Sci USA 83:4494.
20. Fluckiger A C, Rossi J F, Bussel A, Bryon P, Banchereau J, Defrance T. 1992. Responsiveness of lymphocytic leulemia B cells activated via surface Igs or CD40 to B-cell tropic factors. Blood 80:3173.
21. Garcia C A, Rosen A, Aguilar-Santelises M, Jondal M, Mellstedt H. 1993. Higher proliferative response in B-chronic lymphocytic leukemia (B-CLL) as compared to B-monoclonal lymphocytosis of undetermined significance (B-MLUS) after stimulation with Staphylococcus aureus and anti-CD40 monoclonal antibodies. Leuk. Res. 17:933.
22. Planken E V, Dijkstra N H, Kluin-Nelemans J C. 1996. Proliferation of B cell malignancies in all stages of differentiation upon stimulation in the "CD40 system". Leukemia 10:488.
23. Funakoshi S, Longo D L, Beckwith M, Conley D K, Tsarfaty G, Tsarfaty I, Armitage R J, Fanslow W C, Spriggs M K, Murphy W J. 1994. Inhibition of human lymphoma growth by CD40 stimulation. Blood 83:278.
24. Gray D, Siepmann K, van Essen D, Poudrier J, Wykes M, Jainandunsing S, Bergthorsdottir S, Dullforce P. 1996. B-T lymphocyte interactions in the generation and survival of memory cells. Immunol. Rev. 150:46.
25. Fluckiger A C, Garrone P, Durand I, Galizzi J P, Banchereau J. 1993. Interleukin 10 (IL-10) upregulates functional high affinity IL-2 receptors on normal and leukeinic B lymphocytes. J. Exp. Med. 178:1473.
26. Caput D, Laurent P, Kaghad M, Lelias JM, Lefort S, Vita N, Ferrara P. 1996. Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor a chain. J. Biol. Chem. 271:16921.
27. Emilie D, Touitou R, Raphael M, Peuchmaur M, Devergne O, Rea D, Coumbraras J, Crevon M C, Edelman L, Joab I, Galanaud P. 1993. In vivo production of interleukin-10 by malignant cells in AIDS lymphomas. Eur. J. Immunol. 22:2937.
28. Fior R, Vita N, Raphael M, Minty A, Maillot M C, Crevon M C, Caput D, Biberfeld P, Ferrara P, Galanaud P, Emilie D. 1994. Interleukin-13 gene expression by malignant and EBV-transformed human B lymphocytes. Eur. Cytokine Netw. 5:593.
29. Chaouchi N, Wallon C, Goujard C, Tretian G, Rudent A, Caput D, Ferrara P, Minty A, Vasquez A, Delfraissy J F. 1996. Interleukin-13 inhibits interleukin-2-induced proliferation and protects chronic lymphocytic leukemia B cells from in vitro apoptosis. Blood 87:1022.